Article

Dosage of sugammadex according to the calculated lean body mass in obese female patients: time to reverse moderate neuromuscular blockade induced by rocuronium

Published in: Southern African Journal of Anaesthesia and Analgesia
Volume 25 , issue 1 : Entrepreneurship and Africa’s Cultural Context , 2024 , pages: 12–16

DOI: 10.1080/22201181.2019.1571719

Author(s): Cheik Tidiane Hafid Wind-Pouiré Bougouma Department of Anaesthesiology and Intensive Care, Burkina Faso, Jean-Luc RJ Demeere Department of Anaesthesiology, Belgium,

Keywords: calculated lean body mass, neuromuscular blockade, rocuronium, sugammadex,

Download full text Get new issue alerts

Abstract

Background: Sugammadex is a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular blockade. The recommended dose is 2 mg/kg. Based on the pharmacological characteristics of sugammadex in obese patients, the calculated lean body mass (CLBM) should be used to determine the dose to reverse moderate neuromuscular blockade induced by rocuronium.

« Hypotension during spinal anaesthesia for Caesarean section in a resource-limited setting: towards a consensus definition

Awareness of the Ward Based Outreach Team and the services offered by the programme in the Tshwane health district, South Africa »

Article

Dosage of sugammadex according to the calculated lean body mass in obese female patients: time to reverse moderate neuromuscular blockade induced by rocuronium

Abstract

Get new issue alerts for Southern African Journal of Anaesthesia and Analgesia

Latest news

Latest articles